保育器、吸入器、呼吸器、蘇生器、その他の呼吸装置の世界市場

保育器、吸入器、呼吸器、蘇生器、その他の呼吸装置の世界市場は2030年までに354億米ドルに達する見込み

2024年に242億米ドルと推定される保育器、吸入器、呼吸器、蘇生器、その他の呼吸装置の世界市場は、2024～2030年の分析期間においてCAGR 6.6%で成長し、2030年には354億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである喘息アプリケーションは、CAGR 4.7%を記録し、分析期間終了までに119億米ドルに達すると予測されます。COPDアプリケーション分野は、分析期間中にCAGR 7.8％の成長が見込まれます。

米国市場は66億米ドルと推定、中国はCAGR 10.0％で成長予測

米国の保育器、吸入器、呼吸器、蘇生器、その他の呼吸装置市場は、2024年に66億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに72億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは10.0%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.4%と6.3%と予測されています。欧州では、ドイツがCAGR 4.3%で成長すると予測されています。

保育器、吸入器、呼吸器、蘇生器、その他の呼吸装置の世界市場- 主要動向と促進要因のまとめ

生命維持のための呼吸補助装置はクリティカルケアの基幹となるか？

保育器、吸入器、呼吸器、蘇生器、関連する呼吸システムなどの呼吸補助装置の役割は、臨床および救急医療環境の両方で飛躍的に高まっています。これらの技術は、もはや単なる支援用具としてではなく、さまざまな患者の属性や状態にわたって生命を維持するための基礎的な機器と見なされています。新生児集中治療室では、保育器は未熟児や低出生体重児の体温調節と感染制御を確保するために不可欠なものとなっています。気管支拡張薬やコルチコステロイドを投与するための吸入器は、喘息、COPD、アレルギー反応の治療にますます頼りにされています。人工呼吸器と機械式人工呼吸器は、特にパンデミック時や手術後の回復期など、自律呼吸が損なわれている急性呼吸困難の管理で中心的な役割を担っています。救急車や救命救急センターでしばしば使用される蘇生器は、心停止や呼吸停止時に正常な呼吸機能を回復させるために極めて重要です。これらの機器は、慢性疾患の管理にも急性期の介入にも不可欠であり、入院患者、外来患者、在宅介護の場での多面的な応用が強調されています。呼吸器疾患の世界の増加、人口の高齢化、都市部の汚染により、呼吸補助装置は現代医療において常に存在するものとなっています。公衆衛生上の緊急事態においては、呼吸補助装置の拡張性と信頼性が生死を分けることになるため、その重要性はさらに強調されます。病院から災害救助地域に至るまで、あらゆる場面で、これらの機器は患者の生存と回復のための呼吸器の中核を形成しています。

どのような技術革新が効率と患者の転帰を高めているのか？

最先端の技術革新が呼吸補助装置の状況を再定義し、安全性、携帯性、臨床効果の限界を押し上げています。最も注目すべき進歩のひとつは、保育器や人工呼吸器内にスマートモニタリングシステムが統合されたことで、介護者はバイタルサインをリアルタイムで追跡し、侵襲的な介入なしにデータ主導型の意思決定を行うことができます。例えば、最新の保育器には、新生児にとって最も安全な環境を確保するための微気候制御、タッチレスモニタリング、湿度調節機能が装備されています。吸入器も進化し、デジタル用量カウンター、Bluetooth対応のアドヒアランス・トラッカー、さらには音声ガイド付きの使用説明まで搭載され、慢性呼吸器疾患の患者がより効果的に治療を管理できるようになりました。呼吸器は現在、患者のフィードバックに基づいて換気設定を自動的に調整する適応アルゴリズムを備えており、合併症を最小限に抑え、ヘルスケアスタッフの負担を軽減しています。高度な圧力制御機能を備えたバッテリー駆動の軽量蘇生器は、遠隔地や搬送環境での緊急対応効率を向上させています。これらの機器の多くは現在、タッチスクリーン・インターフェイスとクラウドに接続されたデータ・ポータルを備えており、患者の転帰を集中管理された電子カルテにリンクさせることができます。メーカーはまた、抗菌素材、高度なHEPAフィルター、ノイズ低減技術を使用して、衛生と患者の快適性を向上させています。遠隔医療や在宅ヘルスケアの増加に伴い、コンパクトで使い勝手の良い呼吸器への需要が高まっており、人間工学に基づいたデザインやモバイル対応の革新が促されています。このような技術的進歩は、治療成績を向上させるだけでなく、ユーザーエクスペリエンスを向上させ、患者と医療提供者の双方がシームレスで安全なケアジャーニーから利益を得られるようにしています。

公衆衛生上のニーズと臨床上の要請は、どのように機器採用を促進しているのか？

呼吸器疾患の負担の増大とヘルスケア提供モデルの変化が、高度な呼吸補助装置の需要を大きく形成しています。喘息、慢性気管支炎、肺線維症などの慢性呼吸器疾患は、特に高齢化した人口集団や、産業公害やタバコ使用の影響を受けている地域において、より蔓延しつつあります。このような症例の急増により、利用しやすく、効果的で、使い勝手の良い治療機器に対する緊急のニーズが高まっています。保育器は、乳幼児死亡率が高い国や、妊産婦の健康上の合併症により早産が増加している国で需要が高いです。吸入器は、医師が慢性患者に長期吸入療法を処方することが増えているため、家庭用機器になりつつあります。かつては集中治療室に限定されていた呼吸器や人工呼吸器も、現在では外来環境や、特に進行性の神経筋疾患を持つ患者のために、家庭にさえ配備されるようになっています。COVID-19パンデミックのような公衆衛生上の緊急事態は、呼吸器インフラにおける重大なギャップを露呈させ、政府やヘルスケア機関は、こうした機器の備蓄やアップグレードへの投資を増やすように促しました。救急サービスや災害対策チームも、対応能力を強化するため、携帯用蘇生キットや現場対応の呼吸器システムを優先しています。保険業者や政策立案者は、早期呼吸器介入の価値を認識し、患者への償還やアクセスを拡大しています。さらに、世界の健康イニシアチブと非営利団体は、十分なサービスを受けていない地域に呼吸装置を提供することに取り組んでおり、認識と需要を高めています。このような広範な臨床ニーズと公衆衛生ニーズが、先進国市場と新興国市場の両方で呼吸補助技術の採用と継続的な技術革新を加速しています。

呼吸器市場の世界的拡大を後押ししている要因とは？

保育器、吸入器、呼吸器、蘇生器、その他の呼吸器デバイスの世界市場は、人口統計学的、経済的、技術的な影響が混在しているため、急速に拡大しています。主要な推進力は、高齢化する世界人口であり、高齢者はもともと呼吸器合併症を起こしやすく、長期の呼吸補助を必要とします。特にアジア太平洋とアフリカの一部における都市化と工業化は、喘息、肺感染症、大気汚染に関連した健康問題の発生率の上昇につながる環境条件の一因となっています。民間と公的セクターの両方におけるヘルスケア支出の増加により、病院やクリニックは時代遅れの機器をアップグレードし、より新しく効率的なシステムを採用できるようになっています。この成長を支えるもう一つの強力な力は、在宅ヘルスケアへの注目の高まりです。慢性疾患を抱える患者は、コンパクトで携帯可能な呼吸装置を使い、慣れ親しんだ環境で健康管理を行うことを好みます。遠隔モニタリング技術やウェアラブル医療機器の急増は、リアルタイムの監視を提供し、病院の再入院の必要性を減らすことで、この動向を支えています。さらに、医療機関による啓発キャンペーンは、呼吸器系の健康の重要性について一般市民を教育し、これらの機器を使用した早期診断と治療につながっています。政府の資金援助、ヘルスケア改革、いくつかの国における有利な償還政策により、これらの機器はさらに多くの人々が利用できるようになっています。メーカーはまた、病院、薬局、eコマース・プラットフォームと戦略的パートナーシップを結び、流通を拡大し、ラストワンマイル・デリバリーを強化しています。これらの要因が組み合わさることで、呼吸装置市場の持続的成長を支える強固なエコシステムが形成され、呼吸装置は世界の近代的ヘルスケア提供の要として位置付けられています。

セグメント

用途（喘息用途、COPD用途、閉塞性睡眠時無呼吸症候群用途、その他用途）、最終用途（ヘルスケア施設最終用途、製薬企業最終用途）

調査対象企業の例

• Ambu A/S
• BD（Becton, Dickinson & Co.）
• Bio-Med Devices, Inc.
• Dragerwerk AG & Co. KGaA
• Fisher & Paykel Healthcare
• GE HealthCare
• Getinge AB
• Hamilton Medical AG
• HEYER Medical AG
• Hill-Rom Holdings, Inc.（Baxter）
• Inspiration Healthcare Group
• Koninklijke Philips N.V.
• Lowenstein Medical GmbH & Co. KG
• Medtronic plc
• Mindray Medical International
• Nihon Kohden Corporation
• PARI GmbH
• ResMed Inc.
• Smiths Medical（ICU Medical）
• Vyaire Medical, Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices Market to Reach US$35.4 Billion by 2030

The global market for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices estimated at US$24.2 Billion in the year 2024, is expected to reach US$35.4 Billion by 2030, growing at a CAGR of 6.6% over the analysis period 2024-2030. Asthma Application, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$11.9 Billion by the end of the analysis period. Growth in the COPD Application segment is estimated at 7.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$6.6 Billion While China is Forecast to Grow at 10.0% CAGR

The Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices market in the U.S. is estimated at US$6.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$7.2 Billion by the year 2030 trailing a CAGR of 10.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.4% and 6.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Global Market for Incubators, Inhalators, Respirators, Resuscitators, and Other Breathing Devices - Key Trends & Drivers Summarized

How Are Life-Sustaining Respiratory Devices Becoming the Backbone of Critical Care?

The role of respiratory support devices such as incubators, inhalators, respirators, resuscitators, and related breathing systems has grown exponentially in both clinical and emergency care environments. These technologies are no longer seen as mere support tools but as foundational equipment for sustaining life across a wide range of patient demographics and conditions. In neonatal intensive care units, incubators have become essential for ensuring thermal regulation and infection control for premature or low-birth-weight infants. Inhalators, used for delivering bronchodilators and corticosteroids, are increasingly relied upon for the treatment of asthma, COPD, and allergic reactions. Respirators and mechanical ventilators have taken center stage in managing acute respiratory distress, especially during pandemics or post-surgical recovery, where autonomous breathing is impaired. Resuscitators, often used in ambulances and emergency rooms, are crucial for restoring normal respiratory function during cardiac or respiratory arrest. These devices are indispensable in both chronic disease management and acute interventions, highlighting their multifaceted application across inpatient, outpatient, and home care settings. The global rise in respiratory illnesses, aging populations, and urban pollution has made breathing assistance devices a constant presence in modern medicine. Their relevance is further underscored during public health emergencies, where the scalability and reliability of such equipment can mean the difference between life and death. In every setting from hospitals to disaster relief zones, these devices form the respiratory core of patient survival and recovery.

What Technological Innovations Are Enhancing Efficiency and Patient Outcomes?

Cutting-edge innovation is redefining the landscape of breathing support devices, pushing the boundaries of safety, portability, and clinical effectiveness. One of the most notable advancements has been the integration of smart monitoring systems within incubators and respirators, allowing caregivers to track vital signs in real time and make data-driven decisions without invasive intervention. For example, modern incubators are equipped with microclimate control, touchless monitoring, and humidity regulation features that ensure the safest environment for neonates. Inhalators have evolved to include digital dose counters, Bluetooth-enabled adherence trackers, and even voice-guided usage instructions, helping patients with chronic respiratory diseases manage their treatments more effectively. Respirators now come with adaptive algorithms that automatically adjust ventilation settings based on patient feedback, minimizing complications and reducing the burden on healthcare staff. Battery-operated, lightweight resuscitators with advanced pressure control features are improving emergency response efficiency in remote and transport settings. Many of these devices now feature touchscreen interfaces and cloud-connected data portals that link patient outcomes to centralized electronic health records. Manufacturers are also using antimicrobial materials, advanced HEPA filtration, and noise-reduction technology to improve hygiene and patient comfort. With the rise of telemedicine and home healthcare, demand for compact and user-friendly respiratory devices is increasing, prompting innovation in ergonomic design and mobile compatibility. These technological strides are not only improving therapeutic outcomes but are also enhancing user experience, ensuring that both patients and providers benefit from a seamless and safe care journey.

How Are Public Health Needs and Clinical Demands Driving Device Adoption?

The growing burden of respiratory diseases, coupled with changing healthcare delivery models, is significantly shaping the demand for advanced breathing support devices. Chronic respiratory illnesses such as asthma, chronic bronchitis, and pulmonary fibrosis are becoming more prevalent, especially in aging populations and regions affected by industrial pollution and tobacco use. This surge in cases has created a pressing need for accessible, effective, and user-friendly treatment devices. Incubators are in high demand in countries facing high infant mortality rates or where preterm births are on the rise due to maternal health complications. Inhalators are becoming household devices as doctors increasingly prescribe long-term inhalation therapy for chronic patients. Respirators and ventilators, once confined to intensive care units, are now being deployed in ambulatory settings and even homes, particularly for patients with progressive neuromuscular diseases. Public health emergencies such as the COVID-19 pandemic exposed critical gaps in respiratory infrastructure, prompting governments and healthcare institutions to increase investment in stockpiling and upgrading such devices. Emergency services and disaster preparedness teams are also prioritizing portable resuscitation kits and field-ready respiratory systems to enhance response capabilities. Insurance providers and policymakers are recognizing the value of early respiratory intervention, offering greater reimbursement and access to patients. Additionally, global health initiatives and non-profit organizations are working to provide breathing devices to underserved regions, amplifying awareness and demand. These wide-ranging clinical and public health needs are accelerating the adoption and continuous innovation of breathing support technologies across both developed and emerging markets.

What Factors Are Fueling the Global Expansion of the Respiratory Devices Market?

The global market for incubators, inhalators, respirators, resuscitators, and other respiratory devices is expanding rapidly due to a mix of demographic, economic, and technological influences. A key driver is the aging global population, which is inherently more susceptible to respiratory complications and requires long-term breathing assistance. Urbanization and industrialization, particularly in Asia-Pacific and parts of Africa, are contributing to environmental conditions that lead to higher incidences of asthma, lung infections, and air pollution-related health problems. Increased healthcare spending in both private and public sectors is enabling hospitals and clinics to upgrade outdated equipment and adopt newer, more efficient systems. Another powerful force behind this growth is the rising focus on home healthcare, where patients with chronic conditions prefer to manage their health in familiar environments using compact, portable breathing devices. The surge in remote monitoring technologies and wearable medical devices is supporting this trend by providing real-time oversight and reducing the need for hospital readmissions. Additionally, awareness campaigns by health organizations are educating the public about the importance of respiratory health, leading to early diagnosis and treatment using these devices. Government funding, healthcare reforms, and favorable reimbursement policies in several countries are further making these devices accessible to larger sections of the population. Manufacturers are also forming strategic partnerships with hospitals, pharmacies, and e-commerce platforms to broaden distribution and enhance last-mile delivery. The combination of these factors is creating a robust ecosystem that supports sustained growth in the breathing device market, positioning it as a cornerstone of modern healthcare delivery worldwide.

SCOPE OF STUDY:

The report analyzes the Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Asthma Application, COPD Application, Obstructive Sleep Apnea Application, Other Applications); End-Use (Healthcare Settings End-Use, Pharmaceuticals Companies End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

• Ambu A/S
• BD (Becton, Dickinson & Co.)
• Bio-Med Devices, Inc.
• Dragerwerk AG & Co. KGaA
• Fisher & Paykel Healthcare
• GE HealthCare
• Getinge AB
• Hamilton Medical AG
• HEYER Medical AG
• Hill-Rom Holdings, Inc. (Baxter)
• Inspiration Healthcare Group
• Koninklijke Philips N.V.
• Lowenstein Medical GmbH & Co. KG
• Medtronic plc
• Mindray Medical International
• Nihon Kohden Corporation
• PARI GmbH
• ResMed Inc.
• Smiths Medical (ICU Medical)
• Vyaire Medical, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Respiratory Disorders Throws the Spotlight on Breathing Devices as Critical Life-Support Technologies
  • Surge in ICU Admissions and Emergency Care Propels Demand for Advanced Respirators and Resuscitators
  • Here's the Story: Neonatal and Pediatric Care Standards Drive Adoption of Next-Generation Incubators in Hospitals Worldwide
  • Growth in Home-Based Care and Chronic Disease Management Expands Use of Portable Inhalators and CPAP/BiPAP Devices
  • Technological Advancements in Sensor Integration and Smart Monitoring Fuel Innovation in Respiratory Support Equipment
  • Here's How the COVID-19 Pandemic Reshaped Global Investment in Emergency Ventilation Infrastructure
  • Increasing Demand for Non-Invasive Ventilation Solutions Strengthens the Business Case for Patient-Friendly Interfaces
  • Aging Global Population Accelerates Demand for Long-Term Oxygen Therapy and Assisted Breathing Devices
  • Rising Air Pollution and Environmental Triggers Spur Growth in Preventive and Therapeutic Inhalation Devices
  • Digital Health Integration and Telemonitoring Capabilities Enhance Remote Respiratory Management and Device Compliance
  • Global Expansion of Critical Care Infrastructure Creates Opportunities for Advanced ICU-Compatible Respiratory Systems
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Asthma Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Asthma Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Asthma Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for COPD Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for COPD Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for COPD Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Obstructive Sleep Apnea Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Obstructive Sleep Apnea Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Obstructive Sleep Apnea Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Healthcare Settings End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Healthcare Settings End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Healthcare Settings End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Pharmaceuticals Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Pharmaceuticals Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Pharmaceuticals Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 23: USA Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 24: USA Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 25: USA 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Percentage Breakdown of Value Sales for Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 26: USA Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 27: USA Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 28: USA 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Percentage Breakdown of Value Sales for Healthcare Settings End-Use and Pharmaceuticals Companies End-Use for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 29: Canada Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 30: Canada Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 31: Canada 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Percentage Breakdown of Value Sales for Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 32: Canada Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 33: Canada Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 34: Canada 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Percentage Breakdown of Value Sales for Healthcare Settings End-Use and Pharmaceuticals Companies End-Use for the Years 2014, 2025 & 2030
• JAPAN
  • Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 35: Japan Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 36: Japan Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 37: Japan 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Percentage Breakdown of Value Sales for Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 38: Japan Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: Japan Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 40: Japan 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Percentage Breakdown of Value Sales for Healthcare Settings End-Use and Pharmaceuticals Companies End-Use for the Years 2014, 2025 & 2030
• CHINA
  • Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 41: China Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: China Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 43: China 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Percentage Breakdown of Value Sales for Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 44: China Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: China Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 46: China 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Percentage Breakdown of Value Sales for Healthcare Settings End-Use and Pharmaceuticals Companies End-Use for the Years 2014, 2025 & 2030
• EUROPE
  • Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 47: Europe Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 48: Europe Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 49: Europe 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 50: Europe Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Europe Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 52: Europe 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Percentage Breakdown of Value Sales for Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 53: Europe Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Europe Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 55: Europe 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Percentage Breakdown of Value Sales for Healthcare Settings End-Use and Pharmaceuticals Companies End-Use for the Years 2014, 2025 & 2030
• FRANCE
  • Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 56: France Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: France Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 58: France 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Percentage Breakdown of Value Sales for Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 59: France Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: France Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 61: France 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Percentage Breakdown of Value Sales for Healthcare Settings End-Use and Pharmaceuticals Companies End-Use for the Years 2014, 2025 & 2030
• GERMANY
  • Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 62: Germany Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Germany Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 64: Germany 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Percentage Breakdown of Value Sales for Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 65: Germany Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Germany Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 67: Germany 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Percentage Breakdown of Value Sales for Healthcare Settings End-Use and Pharmaceuticals Companies End-Use for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 68: Italy Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Italy Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 70: Italy 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Percentage Breakdown of Value Sales for Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 71: Italy Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Italy Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 73: Italy 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Percentage Breakdown of Value Sales for Healthcare Settings End-Use and Pharmaceuticals Companies End-Use for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 74: UK Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: UK Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 76: UK 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Percentage Breakdown of Value Sales for Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 77: UK Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: UK Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 79: UK 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Percentage Breakdown of Value Sales for Healthcare Settings End-Use and Pharmaceuticals Companies End-Use for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 80: Spain Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Spain Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 82: Spain 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Percentage Breakdown of Value Sales for Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 83: Spain Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Spain Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 85: Spain 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Percentage Breakdown of Value Sales for Healthcare Settings End-Use and Pharmaceuticals Companies End-Use for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 86: Russia Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Russia Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 88: Russia 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Percentage Breakdown of Value Sales for Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 89: Russia Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Russia Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 91: Russia 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Percentage Breakdown of Value Sales for Healthcare Settings End-Use and Pharmaceuticals Companies End-Use for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Rest of Europe Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 94: Rest of Europe 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Percentage Breakdown of Value Sales for Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Rest of Europe Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 97: Rest of Europe 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Percentage Breakdown of Value Sales for Healthcare Settings End-Use and Pharmaceuticals Companies End-Use for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 99: Asia-Pacific Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 100: Asia-Pacific 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Asia-Pacific Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 103: Asia-Pacific 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Percentage Breakdown of Value Sales for Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Asia-Pacific Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 106: Asia-Pacific 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Percentage Breakdown of Value Sales for Healthcare Settings End-Use and Pharmaceuticals Companies End-Use for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 107: Australia Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Australia Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 109: Australia 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Percentage Breakdown of Value Sales for Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 110: Australia Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Australia Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 112: Australia 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Percentage Breakdown of Value Sales for Healthcare Settings End-Use and Pharmaceuticals Companies End-Use for the Years 2014, 2025 & 2030
• INDIA
  • Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 113: India Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: India Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 115: India 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Percentage Breakdown of Value Sales for Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 116: India Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: India Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 118: India 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Percentage Breakdown of Value Sales for Healthcare Settings End-Use and Pharmaceuticals Companies End-Use for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 119: South Korea Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: South Korea Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 121: South Korea 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Percentage Breakdown of Value Sales for Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 122: South Korea Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: South Korea Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 124: South Korea 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Percentage Breakdown of Value Sales for Healthcare Settings End-Use and Pharmaceuticals Companies End-Use for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Rest of Asia-Pacific Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Percentage Breakdown of Value Sales for Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Rest of Asia-Pacific Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Percentage Breakdown of Value Sales for Healthcare Settings End-Use and Pharmaceuticals Companies End-Use for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 131: Latin America Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 132: Latin America Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 133: Latin America 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 134: Latin America Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Latin America Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 136: Latin America 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Percentage Breakdown of Value Sales for Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 137: Latin America Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Latin America Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 139: Latin America 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Percentage Breakdown of Value Sales for Healthcare Settings End-Use and Pharmaceuticals Companies End-Use for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 140: Argentina Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Argentina Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 142: Argentina 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Percentage Breakdown of Value Sales for Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 143: Argentina Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Argentina Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 145: Argentina 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Percentage Breakdown of Value Sales for Healthcare Settings End-Use and Pharmaceuticals Companies End-Use for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 146: Brazil Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Brazil Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 148: Brazil 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Percentage Breakdown of Value Sales for Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 149: Brazil Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Brazil Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 151: Brazil 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Percentage Breakdown of Value Sales for Healthcare Settings End-Use and Pharmaceuticals Companies End-Use for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 152: Mexico Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Mexico Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 154: Mexico 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Percentage Breakdown of Value Sales for Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 155: Mexico Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Mexico Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 157: Mexico 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Percentage Breakdown of Value Sales for Healthcare Settings End-Use and Pharmaceuticals Companies End-Use for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Rest of Latin America Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 160: Rest of Latin America 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Percentage Breakdown of Value Sales for Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Rest of Latin America Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 163: Rest of Latin America 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Percentage Breakdown of Value Sales for Healthcare Settings End-Use and Pharmaceuticals Companies End-Use for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 164: Middle East Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 165: Middle East Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 166: Middle East 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 167: Middle East Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Middle East Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 169: Middle East 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Percentage Breakdown of Value Sales for Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 170: Middle East Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Middle East Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 172: Middle East 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Percentage Breakdown of Value Sales for Healthcare Settings End-Use and Pharmaceuticals Companies End-Use for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 173: Iran Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Iran Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 175: Iran 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Percentage Breakdown of Value Sales for Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 176: Iran Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Iran Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 178: Iran 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Percentage Breakdown of Value Sales for Healthcare Settings End-Use and Pharmaceuticals Companies End-Use for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 179: Israel Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Israel Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 181: Israel 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Percentage Breakdown of Value Sales for Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 182: Israel Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Israel Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 184: Israel 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Percentage Breakdown of Value Sales for Healthcare Settings End-Use and Pharmaceuticals Companies End-Use for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Saudi Arabia Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 187: Saudi Arabia 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Percentage Breakdown of Value Sales for Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Saudi Arabia Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 190: Saudi Arabia 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Percentage Breakdown of Value Sales for Healthcare Settings End-Use and Pharmaceuticals Companies End-Use for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 191: UAE Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: UAE Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 193: UAE 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Percentage Breakdown of Value Sales for Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 194: UAE Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: UAE Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 196: UAE 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Percentage Breakdown of Value Sales for Healthcare Settings End-Use and Pharmaceuticals Companies End-Use for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Middle East Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 199: Rest of Middle East 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Percentage Breakdown of Value Sales for Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Middle East Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 202: Rest of Middle East 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Percentage Breakdown of Value Sales for Healthcare Settings End-Use and Pharmaceuticals Companies End-Use for the Years 2014, 2025 & 2030
• AFRICA
  • Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 203: Africa Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Africa Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 205: Africa 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by Application - Percentage Breakdown of Value Sales for Asthma Application, COPD Application, Obstructive Sleep Apnea Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 206: Africa Recent Past, Current & Future Analysis for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Africa Historic Review for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Healthcare Settings End-Use and Pharmaceuticals Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 208: Africa 16-Year Perspective for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices by End-Use - Percentage Breakdown of Value Sales for Healthcare Settings End-Use and Pharmaceuticals Companies End-Use for the Years 2014, 2025 & 2030

IV. COMPETITION